One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-124994
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 45 |
Affiliation: Oregon Health & Science University, Heidelberg University, University Medical Centre Mannheim, University Hospital Heidelberg, UNSW Sydney, Yale University, Yale Cancer Center, AbbVie (United States), University of Chicago, Munich Leukemia Laboratory (Germany), Royal Perth Hospital, Royal Melbourne Hospital, Massachusetts General Hospital, Liverpool Hospital, Dana-Farber Cancer Institute, University of Colorado Denver, The University of Texas MD Anderson Cancer CenterA Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax As Monotherapy or in Combination with Azacitidine for the Treatment of Relapsed/Refractory Myelodysplastic Syndrome
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
